Fig. 2From: Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinomaKaplan-Meier curve of higher-risk and lower-risk subgroups as stratified by mul-score within different groups of patients. The sets from a to f are: a, all patients; b, testing set; c, patients in AJCC pathologic tumor stage IA; d, patients in AJCC pathologic tumor stage IB; e, patients in AJCC pathologic tumor stage IIB; f, patients in AJCC pathologic tumor stage IIIBack to article page